PCORI 1: Improving Maternal Mental Health & Substance Use Disorder Screening and Treatment

Date Added
November 1st, 2022
PRO Number
Pro00123833
Researcher
Constance Guille

List of Studies


Keywords
Depression, Mental Health, Obstetrics and Gynecology, Post Partum Depression, Pregnancy, Psychiatry, Substance Use, Women's Health
Summary

The purpose of the study is to compare a text message based mental health and substance use screening and referral to treatment program, called Listening to Women and Pregnant and Postpartum People (LTWP), to standard of care mental health and substance use screening to look at treatment attendance and retention in treatment. Participation would involve completing the consent process and then the MUSC study team would collect mental health and substance use screening, referral and treatment data on participant's from their medical records or through the participant's pediatrician. The participant may also be asked to take part in surveys and interviews.

Institution
MUSC
Recruitment Contact
Edie Douglas
843-792-5958
douglaed@musc.edu

Feasibility of a Cannabis Study in Peripartum Women

Date Added
April 19th, 2022
PRO Number
Pro00119473
Researcher
Constance Guille

List of Studies


Keywords
Mental Health, Non-interventional, Pregnancy, Psychiatry, Substance Use, Women's Health
Summary

The purpose of the study is to 1) determine the most practical study recruitment strategies for pregnant and postpartum women with marijuana use and 2) collect data to determine what types of studies pregnant and postpartum women are willing to take part in. Participation involves completing an online survey that takes about 10 minutes to complete.

Institution
MUSC
Recruitment Contact
Edie Douglas
843-792-5958
douglaed@musc.edu

Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome

Date Added
February 7th, 2022
PRO Number
Pro00118200
Researcher
Dorothea Jenkins

List of Studies


Keywords
Infant, Pregnancy
Summary

Neonatal Opioid Withdrawal Syndrome (NOWS) is a condition in which infants undergo withdrawal after exposure to opioids in utero. The current standard of care uses oral morphine and/or methadone which can lead to harmful side effects in the infant. We propose a non-drug based, adjunct treatment that stimulates nerves around the ear, and may help reduce withdrawal symptoms while using less morphine.

Institution
MUSC
Recruitment Contact
Dorothea Jenkins
8437922112
jenkd@musc.edu

A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)

Date Added
December 1st, 2021
PRO Number
Pro00116448
Researcher
Patrick Flume

List of Studies